One of the first nonprofit organizations in New Hampshire to take on the AIDS epidemic says its work isn't done yet.

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

Find lists of blood pressure medications commonly used to treat hypertension and the names of medications prescribed less ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

Dr. Cissy Kityo Mutuluuza has stood at the forefront of HIV/AIDS research in Uganda and around the world with one primary ...

As this vital piece of history goes on display at Tate Modern, Alastair Curtis speaks to those preserving it – and asks why ...

Researchers have never seen anything as close to a potential HIV cure as this new nanoparticle approach. As study authors ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Michigan public health leaders and research scientists say the fallout from Trump administration cuts to federal research ...

Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in ...

A research team in Australia has announced what they believe is a breakthrough in the search for an HIV cure. What makes HIV ...

Lack of treatment for HIV may result in the development of AIDS ... this day is intended to bring people together to work on eliminating prejudice and increasing access to care. The stigma associated ...